Literature DB >> 33457180

What diet should I recommend my patient with Hepatic Encephalopathy?

Jawaid Shaw1, Victoria Tate2, Jennifer Hanson2, Jasmohan S Bajaj3.   

Abstract

PURPOSE OF REVIEW: The burden of malnutrition is high in patients with cirrhosis, especially in those with hepatic encephalopathy (HE). This has a bearing on increased morbidity and mortality. Heightened attention needs to be paid to screen the patients at high nutritional risk both in the outpatient and hospitalized settings. This review summarizes the current evidence for nutritional support in HE patients and compares the recommendations about nutritional requirement as laid out by various organizations. RECENT
FINDINGS: On survey of the literature, there is a consensus on avoiding protein restriction of the diets in HE patients along with uniform recommendations on caloric requirements. An exciting field of manipulating the gut microbiome in nutritional sciences may hold promise as well as there may be a future role for branched chain amino acids in nutritional management of HE patients.
SUMMARY: Even though the data suggest that nutritional improvement lead to better outcomes including lower readmission rates in cirrhosis, operationalizing these into practice remains a challenge. To achieve this, a multi-disciplinary approach with nutritional education of the frontline care providers, earlier nutritional risk screening of patients, involvement of the nutrition professionals as part of the team and repeated dietary counseling for the patient and caregiver/s is required. Ultimately, this may need more focus, resource allocation and uniform guidelines across all countries to make this a success.

Entities:  

Keywords:  Cirrhosis; Guideline adherence; Hepatic Encephalopathy; Nutrition

Year:  2020        PMID: 33457180      PMCID: PMC7810167          DOI: 10.1007/s11901-020-00510-4

Source DB:  PubMed          Journal:  Curr Hepatol Rep        ISSN: 2195-9595


  58 in total

Review 1.  Treatment of hepatic encephalopathy.

Authors:  S M Riordan; R Williams
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

2.  The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.

Authors:  Nasser Mousa; Ahmed Abdel-Razik; Ashraf Zaher; Magdy Hamed; Gamal Shiha; Narmin Effat; Sherif Elbaz; Rania Elhelaly; Mohamed Hafez; Niveen El-Wakeel; Waleed Eldars
Journal:  Therap Adv Gastroenterol       Date:  2016-05-01       Impact factor: 4.409

3.  Comparing assessment tools for detecting undernutrition in patients with liver cirrhosis.

Authors:  M McFarlane; C Hammond; T Roper; J Mukarati; R Ford; J Burrell; V Gordon; N Burch
Journal:  Clin Nutr ESPEN       Date:  2017-11-02

4.  Relation of potassium depletion to renal ammonium metabolism and hepatic coma.

Authors:  G J Gabduzda; P W Hall
Journal:  Medicine (Baltimore)       Date:  1966-11       Impact factor: 1.889

5.  Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.

Authors:  Amit Agrawal; Barjesh Chander Sharma; Praveen Sharma; Shiv Kumar Sarin
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

Review 6.  A practical approach to nutritional screening and assessment in cirrhosis.

Authors:  Puneeta Tandon; Maitreyi Raman; Marina Mourtzakis; Manuela Merli
Journal:  Hepatology       Date:  2017-02-06       Impact factor: 17.425

Review 7.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 8.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

9.  Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.

Authors:  Manuela Merli; Michela Giusto; Cristina Lucidi; Valerio Giannelli; Ilaria Pentassuglio; Vincenza Di Gregorio; Barbara Lattanzi; Oliviero Riggio
Journal:  Metab Brain Dis       Date:  2012-12-07       Impact factor: 3.584

10.  Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease.

Authors:  M Y Morgan; J P Milsom; S Sherlock
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

View more
  3 in total

Review 1.  The Future of Quality Improvement for Cirrhosis.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 6.112

Review 2.  Inadequate practices for hepatic encephalopathy management in the inpatient setting.

Authors:  Jawaid Shaw; Lisa Beyers; Jasmohan S Bajaj
Journal:  J Hosp Med       Date:  2022-08       Impact factor: 2.899

Review 3.  Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.

Authors:  Catherine T Frenette; Cynthia Levy; Sammy Saab
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.